Candid Therapeutics

This early-stage study is testing the safety and side effects of an experimental drug called CND261 in adults with active rheumatoid arthritis. The trial will enroll 47 participants who haven't responded well to current treatments to see how their bodies handle the medication. Re…

This early-stage study is testing a new drug called cizutamig in 44 adults with generalized myasthenia gravis, a chronic autoimmune disease that causes severe muscle weakness. The main goal is to check if the drug is safe and well-tolerated, while also looking for early signs tha…

This early-stage study is testing a new drug called cizutamig in people with systemic lupus erythematosus (lupus). The main goal is to check if the drug is safe and how the body handles it, in 47 adults with active lupus. Researchers will monitor side effects and how the drug mov…

This early-stage study aims to understand how well the body absorbs an experimental drug called cizutamig when given as an injection under the skin compared to directly into a vein. It involves about 20 healthy adult volunteers who will receive a single dose. The main goal is to …